Trial site
Shanghai
- 15running trials
- 5closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)5 trials
- CIDP (chronic inflammatory demyelinating polyneuropathy)4 trials
- Multiple sclerosis3 trials
- Asthma2 trials
- Pompe disease2 trials
- Alopecia areata1 trial
- Gastric and oesophageal cancer1 trial
- Rheumatoid arthritis1 trial
- Phase
- Phase 310 trials
- Phase 27 trials
- Phase 42 trials
- Phase 2/31 trial
- Status
- Active, not recruiting10 trials
- Completed4 trials
- Recruiting4 trials
- Enrolling by invitation1 trial
- Terminated1 trial
- Lead sponsor
- Sanofi18 trials
- Bioverativ, a Sanofi company1 trial
- Genzyme, a Sanofi Company1 trial
Running trials
Recruiting
Recruiting
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
Recruiting
China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With IOPD
Enrolling by invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
Active, not recruiting
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- CIDP (chronic inflammatory demyelinating polyneuropathy)2 recruiting
- Gastric and oesophageal cancer1 recruiting
- Pompe disease1 recruiting
Closed trials
Terminated
Completed
Completed
A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid Arthritis
Completed
Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026